Randomised clinical trial: Faecal microbiota transplantation for irritable bowel syndrome with diarrhoea

Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Meta-Analysis of Randomized Controlled Trials

(2022) Jie Wu et al.   Frontiers in Cellular and Infection Microbiology

Fecal microbiota transplantation in the treatment of irritable bowel syndrome: a single-center prospective study in Japan

(2022) Motonobu Hamazaki et al.   BMC GASTROENTEROLOGY

Omics profiles of fecal and oral microbiota change in irritable bowel syndrome patients with diarrhea and symptom exacerbation

(2022) Yukari Tanaka et al.   JOURNAL OF GASTROENTEROLOGY

Ruminococcus gnavus plays a pathogenic role in diarrhea-predominant irritable bowel syndrome by increasing serotonin biosynthesis

(2022) Lixiang Zhai et al.   Cell Host & Microbe

Gut microbiome signatures reflect different subtypes of irritable bowel syndrome

(2022) Qi Su et al.   Gut Microbes

Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection

(2021) Craig Haifer et al.   mSystems

Sex‐based differences in fecal short‐chain fatty acid and gut microbiota in irritable bowel syndrome patients

(2021) Qing Hua Sun et al.   Journal of Digestive Diseases

Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome

(2021) Magdy El‐Salhy et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century

(2021) Magdy El-Salhy et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome

(2021) Lin Xiao et al.   Frontiers in Cellular and Infection Microbiology

Long-Term Follow-Up Results of Fecal Microbiota Transplantation for Irritable Bowel Syndrome: A Single-Center, Retrospective Study

(2021) Jiaqu Cui et al.   Frontiers in Medicine

The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors

(2021) Hao Lin et al.   Microbial Cell Factories

High prevalence of extended‐spectrum beta‐lactamase organisms and the COVID‐19 pandemic impact on donor recruitment for fecal microbiota transplantation in Hong Kong

(2021) Yuk Kam Yau et al.   United European Gastroenterology Journal

Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome

(2020) Perttu Lahtinen et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study

(2020) Ami D. Sperber et al.   GASTROENTEROLOGY

Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial

(2020) Tom Holvoet et al.   GASTROENTEROLOGY

Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update

(2020) Will Takakura et al.   Frontiers in Psychiatry

Effect of gaseous hydrogen sulphide on growth performance and cecal microbial diversity of weaning pigs

(2020) Jia Cui et al.   Veterinary Medicine and Science

Longitudinal Multi-omics Reveals Subset-Specific Mechanisms Underlying Irritable Bowel Syndrome

(2020) Ruben A.T. Mars et al.   CELL

Changes in fecal short‐chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome

(2020) Magdy El‐Salhy et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Placebo Responses and Placebo Effects in Functional Gastrointestinal Disorders

(2020) Paul Enck et al.   Frontiers in Psychiatry

Fecal Microbiota Transplantation is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection

(2019) Christian Lodberg Hvas et al.   GASTROENTEROLOGY

Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review

(2019) Rapat Pittayanon et al.   GASTROENTEROLOGY

The Effect of Allogenic Versus Autologous Fecal Microbiota Transfer on Symptoms, Visceral Perception and Fecal and Mucosal Microbiota in Irritable Bowel Syndrome

(2019) Savanne Holster et al.   Clinical and Translational Gastroenterology

Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide

(2019) Matthew T. Henke et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increasing the Dose and/or Repeating Faecal Microbiota Transplantation (FMT) Increases the Response in Patients with Irritable Bowel Syndrome (IBS)

(2019) Magdy El-Salhy et al.   Nutrients

Fecal microbiota transplantation in irritable bowel syndrome: A systematic review and meta-analysis

(2019) Kanchana Myneedu et al.   United European Gastroenterology Journal

Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial

(2019) Olga C Aroniadis et al.   Lancet Gastroenterology & Hepatology

Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study

(2019) Magdy El-Salhy et al.   GUT

How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors

(2018) Imran Aziz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis

(2018) Prashant Singh et al.   Clinical Gastroenterology and Hepatology

Faecal microbiota transplantation alters gut microbiota in patients with irritable bowel syndrome: results from a randomised, double-blind placebo-controlled study

(2018) Sofie Ingdam Halkjær et al.   GUT

Fecal Microbiota Transplantation for Primary Clostridium difficile Infection

(2018) Frederik E. Juul et al.   NEW ENGLAND JOURNAL OF MEDICINE

Irritable Bowel Syndrome

(2017) Alexander C. Ford et al.   NEW ENGLAND JOURNAL OF MEDICINE

A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients

(2017) Andrew Brantley Hall et al.   Genome Medicine

Understanding the mechanisms of faecal microbiota transplantation

(2016) Alexander Khoruts et al.   Nature Reviews Gastroenterology & Hepatology

Molecular assessment of differences in the duodenal microbiome in subjects with irritable bowel syndrome

(2015) Evangelos Giamarellos-Bourboulis et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Is Fecal Microbiota Transplantation the Answer for Irritable Bowel Syndrome? A Single-Center Experience

(2014) David M Pinn et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

(2012) Rebecca M. Lovell et al.   Clinical Gastroenterology and Hepatology

The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome

(2012) Emmannouil Pyleris et al.   DIGESTIVE DISEASES AND SCIENCES

Contributions of the microbial hydrogen economy to colonic homeostasis

(2012) Franck Carbonero et al.   Nature Reviews Gastroenterology & Hepatology

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Methane and the Gastrointestinal Tract

(2009) Ara B. Sahakian et al.   DIGESTIVE DISEASES AND SCIENCES

Post-infectious irritable bowel syndrome

(2009) Marroon Thabane et al.   WORLD JOURNAL OF GASTROENTEROLOGY